by Devices and Pharma | May 6, 2025 | Postmarket
Postmarket Surveillance Requirements for PMS in the US and EU Home Request Info QMSR Central QMSR FAQs ISO 13485 Transition Impact Integration Definitions FDA and ISO 13485 ISO 9000 Small Manufacturers What is Postmarket Surveillance (PMS)? Postmarket surveillance...
by Devices and Pharma | May 5, 2025 | Industry Information, Labeling, Med-Devices, Medical Device Labeling, Safety
Medical Device Labeling Home Science Function The Role of a Regulatory Professional Labeling Medical Device Labeling FDA QMSR Central EU IMDRF Training Services Topics Risk Management RAPS Contact U.S. Labeling Requirements for Medical Devices In the world of medical...
by Devices and Pharma | May 4, 2025 | Measurement Analysis and Improvement, Med-Devices, QMSR, QSR, QSR-to-QMSR, Quality system
QMSR Clause 8 - Measurement, Analysis, and Improvement The transition from QSR to QMSR Home QMSR Central Transition Definitions Regulations Small Manufacturers Using Data to Drive Quality, Risk Control, and Continuous Improvement Clause 8 of ISO 13485:2016 defines how...
by Devices and Pharma | May 3, 2025 | Industry Information, ISO 13485, Med-Devices, QMSR, Quality system, US-FDA
QMSR Clause 7 - Product Realization The transition from QSR to QMSR Home QMSR Central Transition Definitions Regulations Small Manufacturers ISO 13485 Clause 7 – Product Realization Clause 7 of ISO 13485, titled Product Realization, outlines the structured...
by Devices and Pharma | Apr 29, 2025 | Industry News, ISO 13485, Med-Devices, QMSR, QSR, QSR-to-QMSR, Quality system, Resource Management
QMSR Clause 6 - Resource Management The transition from QSR to QMSR Home QMSR Central Transition Definitions Regulations Small Manufacturers Ensuring the Organization Has the Capability to Deliver Safe and Effective Medical Devices Clause 6 of ISO 13485:2016 defines...
